Jamil Aboulhosn, MD
Enriched profileStreisand/American Heart Association Chair of Cardiology; Professor of Medicine and Pediatrics; Director, Ahmanson/UCLA Adult Congenital Heart Disease Center · David Geffen School of Medicine at UCLA
Jamil Aboulhosn is Streisand/American Heart Association Chair of Cardiology; Professor of Medicine and Pediatrics; Director, Ahmanson/UCLA Adult Congenital Heart Disease Center at David Geffen School of Medicine at UCLA. OpenAlex indexes 401 publications with 12,161 citations (h-index 49); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Jamil Aboulhosn, MD, is Streisand/American Heart Association Chair of Cardiology at David Geffen School of Medicine at UCLA / Ahmanson-UCLA Adult Congenital Heart Disease Center, University of California, Los Angeles. The public record shows 401 publications with 12,161 citations (h-index 49), centered on Congenital Heart Disease Studies, Cardiac Valve Diseases and Treatments, Pulmonary Hypertension Research and Treatments. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 13 companies.
- Most recent indexed publication: 2026 · European heart journal. Quality of care & clinical outcomes
- Top research focus: Congenital Heart Disease Studies
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 13 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 147.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Transcatheter Valve Implantation in Patients With Dysfunctional Left and Right Sided Heart Valves
Sponsor: University of California, Los Angeles
- Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension
Sponsor: University of California, Los Angeles
- Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease
Sponsor: University of California, Los Angeles
Industry payments
Updated 27 Aug 2026
13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202529 payments$23,465openpaymentsdata.cms.gov ↗
- Edwards Lifesciences CorporationProgram year20259 payments
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.5%Beta blocker19.4%Metoprolol Succinate46%Metoprolol Tartrate20%Carvedilol13%Atenolol11%Propranolol Hcl11%Part D<11 patientsLoop diuretic10.2%Furosemide100%Part D≥31 patientsBlood & clotting
13.8%Factor Xa inhibitor9.3%Eliquis100%Part D≥18 patientsP2Y12 inhibitor2.5%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
9.6%SGLT2 inhibitor7.3%Farxiga100%Part D≥16 patientsPotassium supplement2.3%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Adult congenital cardiac interventional training, competencies, and organization. A Statement of the ESC ACHD Working Group, the EAPCI, the AEPC, and the PICS-Society.
European heart journal. Quality of care & clinical outcomes
Article2026 - Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial.
Circulation. Cardiovascular interventions
Article2026 - Transcatheter Pulmonary Valve Implantation With the Alterra Adaptive Prestent and SAPIEN 3 Transcatheter Heart Valve: 3-Year Pooled Outcomes of the ALTERRA Trials.
Circulation. Cardiovascular interventions
Article2026 - Risk stratification for adult patients with pulmonary arterial hypertension associated with congenital heart disease. A scientific statement of the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, the ESC Working Group on Adult Congenital Heart Disease, and the Association of Cardiovascular Nursing & Allied Professions of the ESC.
European journal of heart failure
Article2026 - New strategies for valve replacement and interventional options in adults with congenital heart disease: new insights from Euro-ACHD 2025.
European heart journal supplements
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 022018 AHA/ACC Guideline for the Management of Adults With Congenital Heart DiseaseArticle1,073 citations2018
- 03
- 04
- 05Arrhythmia Burden in Adults With Surgically Repaired Tetralogy of FallotArticle524 citations2010
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jamil-aboulhosn-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
profiles.ucla.edu/jamil.aboulhosn
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucla.edu ↗ - ResearchGate
researchgate.net/scientific-contributions/Jamil-Aboulhosn-39181207
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
esc365.escardio.org/person/440797
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esc365.escardio.org ↗ - Other
healthinterruptedpodcast.com/drjamilaboulhosn
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthinterruptedpodcast.com ↗ - Other
cardionerds.com/293-achd-interventional-cardiology-with-dr-jamil-aboulhosn-and-dr-joanna-ghobrial-part-1
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardionerds.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedevents.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedevents.com ↗
Editorial & leadership roles
journal and society appointments- Member
ACC/AHA/HRS/ISACHD/SCAI Guideline Writing Committee for the Management of Adults with Congenital Heart Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗ - Chairman
American Board of Internal Medicine (ABIM) ACHD Board Examination Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗ - Chairman
Global Research Working Group, International Society for Adult Congenital Heart Disease
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →isachd.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uclahealth.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uclahealth.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uclahealth.org ↗
Media & interviews
press, podcasts and appearances- Featured guest
Episode 22, Health Interrupted Podcast ("Dr. Jamil Aboulhosn, Renowned Cardiologist Sets Us Straight on Heart Health")
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthinterruptedpodcast.com ↗ - Featured profile
Network 1017
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →network1017.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Finn, MD
David Geffen School of Medicine at UCLA
Edward Garon, MD
David Geffen School of Medicine at UCLA
Donald Tashkin, MD
David Geffen School of Medicine at UCLA
Aditya Bardia, MD
David Geffen School of Medicine at UCLA